Beijing Kangtai Pharmaceutical Co., Ltd. is an innovative enterprise group engaged in pharmaceutical research and development, production, international high-end physical examinations, chronic disease management institutes, high-end nursing homes, and self-operated F2C cross-border e-commerce platforms.
The company has a registered capital of 88.88 million yuan and fixed assets of 200 million yuan. The base is located at No. 1 Keji Road, Miyun Economic Development Zone, Beijing, adjacent to the intersection of Chaohe River and Baihe River. It covers an area of 80,000 square meters, and the existing factory building area is 45,000 square meters. In 2025, a 50,000 square meter international physical examination, chronic disease management center and supporting facilities will be built.
The company has long been market-oriented and technology-led, and has laid a solid foundation for promoting the globalization of innovative drugs with domestic and foreign expert teams. We strive unremittingly for human life and health, insist on R&D investment for our mission, industry-university-research cooperation, resource sharing, mutual benefit and win-win, and are determined to become an innovative enterprise with sustainable competitiveness and innovation in the pharmaceutical industry and chronic disease management.
The purpose of the company is to serve human health, meet the health needs of consumers, and realize its own corporate values; it is the company's sacred mission to revitalize the pharmaceutical industry, serve the country through industry, and benefit mankind. We strive to pursue the most perfect service and realize the lofty ideal of dedicating ourselves to human health.
